Replimune Group Inc sell BMO Capital Markets
Start price
23.07.25
/
50%
€2.40
Target price
23.07.26
€1.70
Performance (%)
141.67%
Price
16.01.26
€6.05
Summary
This prediction is currently active. The price for Replimune Group Inc has massively increased, which is bad news for the SELL prediction by BMO_Capital_Markets. This prediction currently runs until 23.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | -12.319% | -12.319% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-53.10%
16.01.26
16.01.26
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-49.03%
23.11.25
23.11.25